SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

And that’s a problem for American society.

Fresh ideas, big hearts. From transport to fitness and design, a new generation is reshaping the business of eldercare with ...

Total net revenue increased 1,884% to $1.25 million in Q3 2025 from $0.06 million in the same year-ago period. The increase in net contribution revenue was mostly attributable to the addition of sales ...